176 related articles for article (PubMed ID: 28987721)
1. Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.
Bazan HA; Lu Y; Jun B; Fang Z; Woods TC; Hong S
Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():43-47. PubMed ID: 28987721
[TBL] [Abstract][Full Text] [Related]
2. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
[TBL] [Abstract][Full Text] [Related]
3. Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results.
Navarini L; Bisogno T; Margiotta DPE; Piccoli A; Angeletti S; Laudisio A; Ciccozzi M; Afeltra A; Maccarrone M
J Immunol Res; 2018; 2018():5264195. PubMed ID: 30420970
[TBL] [Abstract][Full Text] [Related]
4. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
5. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.
Weiss GA; Troxler H; Klinke G; Rogler D; Braegger C; Hersberger M
Lipids Health Dis; 2013 Jun; 12():89. PubMed ID: 23767972
[TBL] [Abstract][Full Text] [Related]
6. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
7. Native and myeloperoxidase-oxidized low-density lipoproteins act in synergy to induce release of resolvin-D1 from endothelial cells.
Dufour D; Khalil A; Nuyens V; Rousseau A; Delporte C; Noyon C; Cortese M; Reyé F; Pireaux V; Nève J; Vanhamme L; Robaye B; Lelubre C; Desmet JM; Raes M; Boudjeltia KZ; Van Antwerpen P
Atherosclerosis; 2018 May; 272():108-117. PubMed ID: 29597117
[TBL] [Abstract][Full Text] [Related]
8. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
9. Low salivary resolvin D1 to leukotriene B
Thul S; Labat C; Temmar M; Benetos A; Bäck M
Eur J Prev Cardiol; 2017 Jun; 24(9):903-906. PubMed ID: 28195518
[TBL] [Abstract][Full Text] [Related]
10. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
[TBL] [Abstract][Full Text] [Related]
11. Carotid Plaque Rupture Is Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels.
Bazan HA; Hatfield SA; Brug A; Brooks AJ; Lightell DJ; Woods TC
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28779016
[TBL] [Abstract][Full Text] [Related]
12. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
Mas E; Croft KD; Zahra P; Barden A; Mori TA
Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
[TBL] [Abstract][Full Text] [Related]
13. Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome.
Arai K; Koba S; Yokota Y; Tsunoda F; Tsujita H; Kondo S; Tsukamoto S; Shoji M; Shinke T
J Atheroscler Thromb; 2020 Nov; 27(11):1216-1229. PubMed ID: 32595194
[TBL] [Abstract][Full Text] [Related]
14. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
Colas RA; Shinohara M; Dalli J; Chiang N; Serhan CN
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C39-54. PubMed ID: 24696140
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.
Colas RA; Ashton AW; Mukherjee S; Dalli J; Akide-Ndunge OB; Huang H; Desruisseaux MS; Guan F; Jelicks LA; Matos Dos Santos F; Nagajyothi J; Zingman MA; Reyes J; Weiss LM; Serhan CN; Tanowitz HB
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358332
[No Abstract] [Full Text] [Related]
16. Profiling of lipid mediators in atherosclerotic carotid plaques from type 2 diabetic and non-diabetic patients.
Ménégaut L; Laubriet A; Crespy V; Nguyen M; Petit JM; Tarris G; Pilot T; Varin A; Choubley H; Bergas V; de Barros JP; Thomas C; Steinmetz E; Masson D
Prostaglandins Leukot Essent Fatty Acids; 2022 Sep; 184():102477. PubMed ID: 35952424
[TBL] [Abstract][Full Text] [Related]
17. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
Iwamatsu K; Abe S; Nishida H; Kageyama M; Nasuno T; Sakuma M; Toyoda S; Inoue T
Hypertens Res; 2016 Apr; 39(4):272-5. PubMed ID: 26739870
[TBL] [Abstract][Full Text] [Related]
18. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.
Serhan CN; Arita M; Hong S; Gotlinger K
Lipids; 2004 Nov; 39(11):1125-32. PubMed ID: 15726828
[TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder.
Kok Kendirlioglu B; Unalan Ozpercin P; Yuksel Oksuz O; Sozen S; Cihnioglu R; Kalelioglu T; Ilnem MC; Karamustafalioglu N
Nord J Psychiatry; 2020 Feb; 74(2):83-88. PubMed ID: 31575320
[No Abstract] [Full Text] [Related]
20. Acute Coronary Syndrome May be Associated with Decreased Resolvin D1-to-Leukotriene B4 Ratio.
Sun C; Zheng W; Liang L; Zhang Z; Liu Z; Sun W; Zhou J; Qiao W; Xie Q; Tang R
Int Heart J; 2023 Mar; 64(1):22-27. PubMed ID: 36682769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
